当前位置:首页 - 行情中心 - 大洋生物(003017) - 财务分析 - 现金流量表

大洋生物

(003017)

  

流通市值:23.22亿  总市值:28.15亿
流通股本:6928.80万   总股本:8400.00万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金645,725,620.44411,750,321.67213,380,946.05852,699,943.77
  收到的税费返还23,032,674.3715,111,664.923,632,465.5912,396,404.72
  收到其他与经营活动有关的现金25,361,626.9320,281,445.0211,503,365.6224,233,561.47
  经营活动现金流入小计694,119,921.74447,143,431.61228,516,777.26889,329,909.96
  购买商品、接受劳务支付的现金428,494,582.57229,069,598.05125,653,067.76625,139,166.96
  支付给职工以及为职工支付的现金88,001,937.4561,707,141.9135,281,839.06119,136,230.62
  支付的各项税费38,524,509.1625,744,044.9714,268,38736,869,375.25
  支付其他与经营活动有关的现金25,318,669.4617,254,670.9310,702,513.0441,991,178.47
  经营活动现金流出小计580,339,698.64333,775,455.86185,905,806.86823,135,951.3
  经营活动产生的现金流量净额113,780,223.1113,367,975.7542,610,970.466,193,958.66
二、投资活动产生的现金流量:
  收回投资收到的现金88,000,00071,000,00068,000,00089,000,000
  取得投资收益收到的现金807,031.44581,027.61539,082.221,204,681.5
  处置固定资产、无形资产和其他长期资产收回的现金净额---941,902.22
  收到的其他与投资活动有关的现金493,098.74---
  投资活动现金流入小计89,300,130.1871,581,027.6168,539,082.2291,146,583.72
  购建固定资产、无形资产和其他长期资产支付的现金44,826,614.6627,156,127.0216,070,825.2463,449,820.47
  投资支付的现金48,000,00048,000,00048,000,000195,000,000
  投资活动现金流出小计92,826,614.6675,156,127.0264,070,825.24258,449,820.47
  投资活动产生的现金流量净额-3,526,484.48-3,575,099.414,468,256.98-167,303,236.75
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,900,0001,940,0001,940,0001,000,000
  其中:子公司吸收少数股东投资收到的现金3,900,0001,940,0001,940,0001,000,000
  取得借款收到的现金556,000,000383,000,00070,000,000715,857,344.94
  收到其他与筹资活动有关的现金14,977,959.9612,266,823.8-35,849,216.47
  筹资活动现金流入小计574,877,959.96397,206,823.871,940,000752,706,561.41
  偿还债务支付的现金562,532,232.75448,437,232.75115,470,872.21598,499,641.3
  分配股利、利润或偿付利息支付的现金28,249,319.5327,466,684.591,052,267.3642,707,190.2
  支付其他与筹资活动有关的现金4,405,438.734,440,642.43,981,37144,935,673.82
  筹资活动现金流出小计595,186,991.01480,344,559.74120,504,510.57686,142,505.32
  筹资活动产生的现金流量净额-20,309,031.05-83,137,735.94-48,564,510.5766,564,056.09
四、汇率变动对现金及现金等价物的影响698,390.46577,899.16430,911.33265,205
五、现金及现金等价物净增加额90,643,098.0327,233,039.56-1,054,371.86-34,280,017
  加:期初现金及现金等价物余额347,244,440.16347,244,440.16347,244,440.16381,524,457.16
  期末现金及现金等价物余额437,887,538.19374,477,479.72346,190,068.3347,244,440.16
补充资料:
  净利润-50,295,967.72-63,735,511.21
  资产减值准备-13,679,742.76-8,957,738.67
  固定资产和投资性房地产折旧-30,764,320.36-64,976,473.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-30,764,320.36-64,976,473.25
  无形资产摊销-1,453,203.45-2,835,046.37
  长期待摊费用摊销-47,169.81-236,563.64
  处置固定资产、无形资产和其他长期资产的损失----85,131.93
  固定资产报废损失-1,980,303.87-3,212,788.68
  公允价值变动损失--296,228.9--1,472,424.84
  财务费用-2,408,848.38-6,502,006.56
  投资损失-1,121,628.15--728,520.93
  递延所得税-6,914,161.51-7,753,784.02
  其中:递延所得税资产减少-5,608,278.02-11,857,412.35
    递延所得税负债增加-1,305,883.49--4,103,628.33
  存货的减少--1,482,081.81-30,200,175.62
  经营性应收项目的减少--6,535,572.39--94,511,088.78
  经营性应付项目的增加-12,585,981.49--30,750,901.69
  其他---4,460,511.44
  现金的期末余额-374,477,479.72-347,244,440.16
  减:现金的期初余额-347,244,440.16-381,524,457.16
  现金及现金等价物的净增加额-27,233,039.56--34,280,017
公告日期2025-10-212025-08-262025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑